16
Jun
2020
Groups audience:
Dear all,
We will have our last call for the subgroup, but it does not mean our work stops. We will discuss a few ideas to follow up on our recommendations and guidelines.
1. What are the use cases for our recommendations and guidelines
2. What do we want to leverage our writing so far? To develop it into a white paper or a publication?
We welcome you to join us 13.00 UTC on June 17, 2020 at https://global.gotomeeting.com or use the direct URL https://global.gotomeeting.com/join/903049133
Co-Moderators: Sergio Bonini (***@***.***), Andrea Jackson-Dipina (***@***.***), Dawei Lin (***@***.***), Christian Ohmann ( ***@***.***-duesseldorf.de )
Co-Chair Liaison: Anne Cambon-Thomsen (***@***.***-tlse3.fr)
- Log in to post comments
- 1322 reads
Author: Martin Golebiewski
Date: 17 Jun, 2020
Dear Dawei,
Dear all,
What is the time frame for the meeting?
Actually, I have 3 (!!) other meetings (ISO meetings) in parallel already, so I only could join in for short time and only later in this meeting.
Thanks and best regards,
Martin
------------------------------------------
Martin Golebiewski
HITS gGmbH
Schloss-Wolfsbrunnenweg 35
69118 Heidelberg
Germany
phone +49 6221 533 281
fax +49 6221 533 298
email ***@***.***-its.org
http://www.h-its.org
_________________________________________________
Amtsgericht Mannheim / HRB 337446
Managing Director: Dr. Gesa Schönberger
Scientific Director: PD Wolfgang Müller
Von: <***@***.***-groups.org> im Auftrag von daweilin via RDA-COVID19-Clinical <***@***.***-groups.org>
Antworten an: "***@***.***" <***@***.***>
Datum: Dienstag, 16. Juni 2020 um 21:40
An: "***@***.***-groups.org" <***@***.***-groups.org>
Cc: "Jackson-Dipina, Andrea (NIH/OD) [E]" <***@***.***>, Sergio Bonini <***@***.***>, Anne Cambon-Thomsen <***@***.***-tlse3.fr>, "***@***.***-duesseldorf.de" <***@***.***-duesseldorf.de>
Betreff: [rda-covid19-clinical] Last Clinical Subgroup call on use cases and future steps
Dear all,
We will have our last call for the subgroup, but it does not mean our work stops. We will discuss a few ideas to follow up on our recommendations and guidelines.
1. What are the use cases for our recommendations and guidelines
2. What do we want to leverage our writing so far? To develop it into a white paper or a publication?
We welcome you to join us 13.00 UTC on June 17, 2020 at https://global.gotomeeting.com or use the direct URL https://global.gotomeeting.com/join/903049133
Co-Moderators: Sergio Bonini (***@***.***), Andrea Jackson-Dipina (***@***.***), Dawei Lin (***@***.***), Christian Ohmann ( ***@***.***-duesseldorf.de )
Co-Chair Liaison: Anne Cambon-Thomsen (***@***.***-tlse3.fr)
Author: Dawei Lin
Date: 17 Jun, 2020
Hi Martin,
Thank you for letting us know. Today meeting is open and depends on the use cases. So we may end early. We can always catch up if you can not join us.
Dawei
From: "Golebiewski, Martin" <***@***.***-its.org>
Date: Wednesday, June 17, 2020 at 8:38 AM
To: "Lin, Dawei (NIH/NIAID) [E]" <***@***.***>, "***@***.***-groups.org" <***@***.***-groups.org>
Cc: "Jackson-Dipina, Andrea (NIH/OD) [E]" <***@***.***>, Sergio Bonini <***@***.***>, Anne Cambon-Thomsen <***@***.***-tlse3.fr>, "***@***.***-duesseldorf.de" <***@***.***-duesseldorf.de>
Subject: Re: [rda-covid19-clinical] Last Clinical Subgroup call on use cases and future steps
Dear Dawei,
Dear all,
What is the time frame for the meeting?
Actually, I have 3 (!!) other meetings (ISO meetings) in parallel already, so I only could join in for short time and only later in this meeting.
Thanks and best regards,
Martin
------------------------------------------
Martin Golebiewski
HITS gGmbH
Schloss-Wolfsbrunnenweg 35
69118 Heidelberg
Germany
phone +49 6221 533 281
fax +49 6221 533 298
email ***@***.***-its.org
http://www.h-its.org
_________________________________________________
Amtsgericht Mannheim / HRB 337446
Managing Director: Dr. Gesa Schönberger
Scientific Director: PD Wolfgang Müller
Von: <***@***.***-groups.org> im Auftrag von daweilin via RDA-COVID19-Clinical <***@***.***-groups.org>
Antworten an: "***@***.***" <***@***.***>
Datum: Dienstag, 16. Juni 2020 um 21:40
An: "***@***.***-groups.org" <***@***.***-groups.org>
Cc: "Jackson-Dipina, Andrea (NIH/OD) [E]" <***@***.***>, Sergio Bonini <***@***.***>, Anne Cambon-Thomsen <***@***.***-tlse3.fr>, "***@***.***-duesseldorf.de" <***@***.***-duesseldorf.de>
Betreff: [rda-covid19-clinical] Last Clinical Subgroup call on use cases and future steps
Dear all,
We will have our last call for the subgroup, but it does not mean our work stops. We will discuss a few ideas to follow up on our recommendations and guidelines.
1. What are the use cases for our recommendations and guidelines
2. What do we want to leverage our writing so far? To develop it into a white paper or a publication?
We welcome you to join us 13.00 UTC on June 17, 2020 at https://global.gotomeeting.com or use the direct URL https://global.gotomeeting.com/join/903049133
Co-Moderators: Sergio Bonini (***@***.***), Andrea Jackson-Dipina (***@***.***), Dawei Lin (***@***.***), Christian Ohmann ( ***@***.***-duesseldorf.de )
Co-Chair Liaison: Anne Cambon-Thomsen (***@***.***-tlse3.fr)